Literature DB >> 21940153

Does cardiovascular phenotype explain the association between diabetes and incident heart failure? The Strong Heart Study.

G de Simone1, R B Devereux, M J Roman, M Chinali, A Barac, J A Panza, E T Lee, J M Galloway, B V Howard.   

Abstract

BACKGROUND AND AIMS: Diabetes remains a predictor of incident heart failure (HF), independent of intercurrent myocardial infarction (MI) and concomitant risk factors. Initial cardiovascular (CV) characteristics, associated with incident heart failure (HF) might explain the association of diabetes with incident HF. METHODS AND
RESULTS: Participants to the 2nd Strong Heart Study exam, without prevalent HF or coronary heart disease, or glomerular filtration rate <30 mL/min/1.73 m(2), were analyzed (n = 2757, 1777 women, 1278 diabetic). Cox regression of incident HF (follow-up 8.91 ± 2.76 years) included incident MI censored as a competing risk event. Acute MI occurred in 96 diabetic (7%) and 84 non-diabetic participants (6%, p = ns). HF occurred in 156 diabetic (12%) and in 68 non-diabetic participants (5%; OR = 2.89, p < 0.001). After accounting for competing MI and controlling for age, gender, BMI, systolic blood pressure, smoking habit, plasma cholesterol, antihypertensive treatment, heart rate, fibrinogen and C-reactive protein, incident HF was predicted by greater LV mass index, larger left atrium, lower systolic function, greater left atrial systolic force and urinary albumin/creatinine excretion. Risk of HF was reduced with more rapid LV relaxation and anti-hypertensive therapy. Diabetes increases hazard of HF by 66% (0.02 < p < 0.001). The effect of diabetes could be explained by the level of HbA1c.
CONCLUSIONS: Incident HF occurs more frequently in diabetes, independent of intercurrent MI, abnormal LV geometry, subclinical systolic dysfunction and indicators of less rapid LV relaxation, and is influenced by poor metabolic control. Identification of CV phenotype at high-risk for HF in diabetes should be advised.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21940153      PMCID: PMC3246029          DOI: 10.1016/j.numecd.2011.06.007

Source DB:  PubMed          Journal:  Nutr Metab Cardiovasc Dis        ISSN: 0939-4753            Impact factor:   4.222


  35 in total

1.  The Strong Heart Study. A study of cardiovascular disease in American Indians: design and methods.

Authors:  E T Lee; T K Welty; R Fabsitz; L D Cowan; N A Le; A J Oopik; A J Cucchiara; P J Savage; B V Howard
Journal:  Am J Epidemiol       Date:  1990-12       Impact factor: 4.897

2.  Left ventricular mass predicts heart failure not related to previous myocardial infarction: the Cardiovascular Health Study.

Authors:  Giovanni de Simone; John S Gottdiener; Marcello Chinali; Mathew S Maurer
Journal:  Eur Heart J       Date:  2008-01-19       Impact factor: 29.983

3.  The progression from hypertension to congestive heart failure.

Authors:  D Levy; M G Larson; R S Vasan; W B Kannel; K K Ho
Journal:  JAMA       Date:  1996 May 22-29       Impact factor: 56.272

4.  Evaluation of methods for estimation of total arterial compliance.

Authors:  N Stergiopulos; J J Meister; N Westerhof
Journal:  Am J Physiol       Date:  1995-04

5.  Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements.

Authors:  D J Sahn; A DeMaria; J Kisslo; A Weyman
Journal:  Circulation       Date:  1978-12       Impact factor: 29.690

Review 6.  Role of preclinical cardiovascular disease in the evolution from risk factor exposure to development of morbid events.

Authors:  R B Devereux; M H Alderman
Journal:  Circulation       Date:  1993-10       Impact factor: 29.690

7.  Quantitative analysis of myocardial structure in insulin-dependent diabetes mellitus: effects of immediate and delayed insulin replacement.

Authors:  E W Thompson
Journal:  Proc Soc Exp Biol Med       Date:  1994-04

8.  Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight.

Authors:  G de Simone; S R Daniels; R B Devereux; R A Meyer; M J Roman; O de Divitiis; M H Alderman
Journal:  J Am Coll Cardiol       Date:  1992-11-01       Impact factor: 24.094

9.  Midwall left ventricular mechanics. An independent predictor of cardiovascular risk in arterial hypertension.

Authors:  G de Simone; R B Devereux; M J Koren; G A Mensah; P N Casale; J H Laragh
Journal:  Circulation       Date:  1996-01-15       Impact factor: 29.690

10.  Coronary heart disease prevalence and its relation to risk factors in American Indians. The Strong Heart Study.

Authors:  B V Howard; E T Lee; L D Cowan; R R Fabsitz; W J Howard; A J Oopik; D C Robbins; P J Savage; J L Yeh; T K Welty
Journal:  Am J Epidemiol       Date:  1995-08-01       Impact factor: 4.897

View more
  6 in total

Review 1.  Heart failure as a risk factor for osteoporosis and fractures.

Authors:  Aloice O Aluoch; Ryan Jessee; Hani Habal; Melinda Garcia-Rosell; Rehan Shah; Guy Reed; Laura Carbone
Journal:  Curr Osteoporos Rep       Date:  2012-12       Impact factor: 5.096

2.  Biological significance of miR-126 expression in atrial fibrillation and heart failure.

Authors:  X J Wei; M Han; F Y Yang; G C Wei; Z G Liang; H Yao; C W Ji; R S Xie; C L Gong; Y Tian
Journal:  Braz J Med Biol Res       Date:  2015-08-25       Impact factor: 2.590

3.  Target organ damage and incident type 2 diabetes mellitus: the Strong Heart Study.

Authors:  Giovanni de Simone; Wenyu Wang; Lyle G Best; Fawn Yeh; Raffaele Izzo; Costantino Mancusi; Mary J Roman; Elisa T Lee; Barbara V Howard; Richard B Devereux
Journal:  Cardiovasc Diabetol       Date:  2017-05-12       Impact factor: 9.951

4.  Myocardial mechano-energetic efficiency and insulin resistance in non-diabetic members of the Strong Heart Study cohort.

Authors:  Costantino Mancusi; Giovanni de Simone; Lyle G Best; Wenyu Wang; Ying Zhang; Mary J Roman; Elisa T Lee; Barbara V Howard; Richard B Devereux
Journal:  Cardiovasc Diabetol       Date:  2019-04-30       Impact factor: 9.951

Review 5.  Bedside-to-Bench Translational Research for Chronic Heart Failure: Creating an Agenda for Clients Who Do Not Meet Trial Enrollment Criteria.

Authors:  P Iyngkaran; M Thomas
Journal:  Clin Med Insights Cardiol       Date:  2015-08-05

6.  Pathophysiological effects of different risk factors for heart failure.

Authors:  Hong Yang; Ying Wang; Kazuaki Negishi; Mark Nolan; Thomas H Marwick
Journal:  Open Heart       Date:  2016-03-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.